The influence of carbamazepine on the heme biosynthetic pathway

Nili Schoenfeld*, Yehudit Greenblat, Orit Epstein, Abraham Atsmon

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Abstract

Carbamazepine, a drug which is widely used in neurological diseases, has a porphyrogenic effect in chick embryo liver cells in culture. It increased the concentration of cellular porphyrins by 80-fold and δ-aminolevulinate synthase activity by 4-fold. The increase in the accumulation of porphyrins preceded that of ALAS activity. Measurements of the activities of aminolevulinate dehydrase, porphobilinogen deaminase, and uroporphyrinogen decarboxylase showed that C inhibits UROD up to nearly 50% and PBGD activity up to 20%, but does not affect the activity of ALAD. The pattern of accumulation of porphyrins, mainly uro- and heptacarboxylporphyrin, is compatible with an inhibition of UROD. We may, therefore, conclude that the porphyrogenic effect of C in monolayers of chick embryo liver cells is the sesult of its inhibitory effect on the activity of UROD.

Original languageEnglish
Pages (from-to)280-286
Number of pages7
JournalBiochemical Medicine
Volume34
Issue number3
DOIs
StatePublished - Dec 1985
Externally publishedYes

Fingerprint

Dive into the research topics of 'The influence of carbamazepine on the heme biosynthetic pathway'. Together they form a unique fingerprint.

Cite this